Aelis Farma S.A. (AELIS.PA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-223.5%

-€0.91

vs €0.74 price

Levered DCF

-€1.02

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

-1.02

Distress zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-2.4×	-3.7×	-33.46×	-11.19×	210.7×	-57.27×	-37.06×	-45×
P/B	3.49×	2.71×	12.75×	8.1×	134.45×	-170.24×	100.39×	50.68×
P/S	7.43×	10.24×	18.59×	42.09×	13.32×	106.3×	13,655.93×	3,024.89×
EV / EBITDA	-1.73×	-2.73×	-23.97×	-8×	121.53×	-34.34×	-26.54×	-34.19×
Gross margin	-13.4%	100.0%	100.0%	100.0%	100.0%	97.4%	-35314.3%	-7150.0%
Operating margin	-397.4%	-288.8%	-71.4%	-223.8%	28.1%	-355.8%	-33781.5%	-6584.4%
Net margin	-308.7%	-278.4%	-56.1%	-375.1%	6.3%	-183.5%	-35826.5%	-6834.7%
Current ratio	4.4×	3.77×	2.48×	2.45×	1.97×	3.73×	5.53×	3.66×
Debt / equity	1.49×	0.62×	0.31×	0.19×	7.13×	-8.61×	3.86×	1.29×
Interest coverage	-28.85×	-37.55×	-41.15×	-76.12×	18.23×	-29.32×	-28.75×	-42.44×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-144.9%	-73.7%	-38.5%	-72.2%	63.8%	293.8%	-263.4%	-114.5%
Return on invested capital	-67.0%	-46.8%	-37.3%	-35.1%	5.5%	-52.5%	-48.2%	-47.5%
Return on assets	-53.4%	-37.8%	-19.3%	-36.4%	2.0%	-29.8%	-43.9%	-43.3%
Free cash flow yield	-34.8%	-42.7%	-7.5%	-8.2%	15.5%	-2.1%	-2.4%	-3.0%
Earnings yield	-41.5%	-27.2%	-3.0%	-8.9%	0.5%	-1.7%	-2.6%	-2.3%
Enterprise value	€13.9M	€19.6M	€152.1M	€129.7M	€102.6M	€122.4M	€119.7M	€118.8M
Net debt / EBITDA	0.2×	1.09×	2.55×	1.88×	-21.68×	-0.44×	0.25×	0.59×
Cash conversion cycle (days)	168	336	77	131	65	-10,837	-39	-54